373 related articles for article (PubMed ID: 31563654)
21. The Global Limb Anatomic Staging System is associated with outcomes of infrainguinal revascularization in chronic limb threatening ischemia.
El Khoury R; Wu B; Edwards CT; Lancaster EM; Hiramoto JS; Vartanian SM; Schneider PA; Conte MS
J Vasc Surg; 2021 Jun; 73(6):2009-2020.e4. PubMed ID: 33548444
[TBL] [Abstract][Full Text] [Related]
22. Analysis of endovascular therapy for femoropopliteal disease with the Supera stent.
Montero-Baker M; Ziomek GJ; Leon L; Gonzales A; Dieter RS; Gadd CL; Pacanowski JP
J Vasc Surg; 2016 Oct; 64(4):1002-8. PubMed ID: 27444365
[TBL] [Abstract][Full Text] [Related]
23. Endovascular recanalization of infrapopliteal occlusions in patients with critical limb ischemia.
Singh GD; Armstrong EJ; Yeo KK; Singh S; Westin GG; Pevec WC; Dawson DL; Laird JR
J Vasc Surg; 2014 May; 59(5):1300-7. PubMed ID: 24393279
[TBL] [Abstract][Full Text] [Related]
24. Long-Term Follow-up of the PADI Trial: Percutaneous Transluminal Angioplasty Versus Drug-Eluting Stents for Infrapopliteal Lesions in Critical Limb Ischemia.
Spreen MI; Martens JM; Knippenberg B; van Dijk LC; de Vries JPM; Vos JA; de Borst GJ; Vonken EPA; Bijlstra OD; Wever JJ; Statius van Eps RG; Mali WPTM; van Overhagen H
J Am Heart Assoc; 2017 Apr; 6(4):. PubMed ID: 28411244
[TBL] [Abstract][Full Text] [Related]
25. A systematic review and meta-analysis of revascularization outcomes of infrainguinal chronic limb-threatening ischemia.
Almasri J; Adusumalli J; Asi N; Lakis S; Alsawas M; Prokop LJ; Bradbury A; Kolh P; Conte MS; Murad MH
J Vasc Surg; 2018 Aug; 68(2):624-633. PubMed ID: 29804736
[TBL] [Abstract][Full Text] [Related]
26. Registry Assessment of Peripheral Interventional Devices objective performance goals for superficial femoral and popliteal artery peripheral vascular interventions.
Bertges DJ; White R; Cheng YC; Sun T; Ramkumar N; Goodney PP; Wilgus RW; Lottes AE; Smale JA; Drozda J; Raska M; Heise T; Jones WS; Tcheng JE; Eldrup-Jorgensen J; Sedrakyan A; Malone ML; Marinac-Dabic D; Thatcher R; Morales P; Krucoff MW; Cronenwett JL;
J Vasc Surg; 2021 May; 73(5):1702-1714.e11. PubMed ID: 33080324
[TBL] [Abstract][Full Text] [Related]
27. Six-year multicenter experience of standard endovascular treatment of critical limb ischemia in the era of drug-eluting devices.
Brizzi V; Caradu C; Berard X; Sassoust G; Midy D; Ducasse E
J Cardiovasc Surg (Torino); 2018 Oct; 59(5):707-715. PubMed ID: 27879958
[TBL] [Abstract][Full Text] [Related]
28. Bypass versus endovascular intervention for healing ischemic foot wounds secondary to tibial arterial disease.
Mohapatra A; Henry JC; Avgerinos ED; Boitet A; Chaer RA; Makaroun MS; Leers SA; Hager ES
J Vasc Surg; 2018 Jul; 68(1):168-175. PubMed ID: 29336904
[TBL] [Abstract][Full Text] [Related]
29. Efficacy and one-year outcomes of Luminor® paclitaxel-coated drug-eluting balloon in the treatment of popliteal artery atherosclerosis lesions.
Pecoraro F; Dinoto E; Pakeliani D; Mirabella D; Ferlito F; Bajardi G
Ann Vasc Surg; 2021 Oct; 76():370-377. PubMed ID: 33951533
[TBL] [Abstract][Full Text] [Related]
30. Editor's Choice - Dual Antiplatelet Therapy Improves Outcome in Diabetic Patients Undergoing Endovascular Femoropopliteal Stenting for Critical Limb Ischaemia.
Thott O; Granath F; Malmstedt J; Wahlgren CM
Eur J Vasc Endovasc Surg; 2017 Mar; 53(3):403-410. PubMed ID: 28131536
[TBL] [Abstract][Full Text] [Related]
31. Endovascular treatment of TransAtlantic Inter-Society Consensus II D femoropopliteal lesions in patients with critical limb ischemia.
Biagioni RB; Brandão GD; Biagioni LC; Nasser F; Burihan MC; Ingrund JC
J Vasc Surg; 2019 May; 69(5):1510-1518. PubMed ID: 30611581
[TBL] [Abstract][Full Text] [Related]
32. Primary everolimus-eluting stenting versus balloon angioplasty with bailout bare metal stenting of long infrapopliteal lesions for treatment of critical limb ischemia.
Karnabatidis D; Spiliopoulos S; Diamantopoulos A; Katsanos K; Kagadis GC; Kakkos S; Siablis D
J Endovasc Ther; 2011 Feb; 18(1):1-12. PubMed ID: 21314342
[TBL] [Abstract][Full Text] [Related]
33. Multidisciplinary approach achieves limb salvage without revascularization in patients with mild to moderate ischemia and tissue loss.
Gabel J; Bianchi C; Possagnoli I; Mehta R; Abou-Zamzam AM; Teruya T; Kiang S; Bishop V; Valenzuela A
J Vasc Surg; 2020 Jun; 71(6):2073-2080.e1. PubMed ID: 31727460
[TBL] [Abstract][Full Text] [Related]
34. Predictors of major adverse lower limb events in patients with tissue loss secondary to critical limb-threatening ischemia.
Vosgin-Dinclaux V; Bertucat P; Dari L; Webster C; Foussard N; Mohammedi K; Ducasse E; Caradu C
Cardiovasc Revasc Med; 2024 Jul; 64():34-41. PubMed ID: 38350775
[TBL] [Abstract][Full Text] [Related]
35. Safety and Efficacy of Drug-Coated Balloon Angioplasty for the Treatment of Chronic Limb-Threatening Ischemia: A Systematic Review and Meta-Analysis.
Giannopoulos S; Ghanian S; Parikh SA; Secemsky EA; Schneider PA; Armstrong EJ
J Endovasc Ther; 2020 Aug; 27(4):647-657. PubMed ID: 32508220
[No Abstract] [Full Text] [Related]
36. Safety, clinical outcome, and fracture rate of femoropopliteal stenting using a 4F compatible delivery system.
Sarkadi H; Bérczi V; Kollár A; Kiss D; Jakabfi P; Végh EM; Nemes B; Merkely B; Hüttl K; Dósa E
Eur J Vasc Endovasc Surg; 2015 Feb; 49(2):199-204. PubMed ID: 25579877
[TBL] [Abstract][Full Text] [Related]
37. Long-term outcome of femoropopliteal stenting. Results of a prospective study.
Schönefeld E; Torsello G; Osada N; Herten M; Bisdas T; Donas KP
J Cardiovasc Surg (Torino); 2013 Oct; 54(5):617-23. PubMed ID: 24002391
[TBL] [Abstract][Full Text] [Related]
38. Prior Endovascular Intervention Is Not Detrimental to Pedal Bypasses for Ischemic Wounds.
Mohapatra A; Lowenkamp MN; Henry JC; Boitet A; Avgerinos ED; Chaer RA; Makaroun MS; Leers SA; Hager ES
Ann Vasc Surg; 2018 Jul; 50():80-87. PubMed ID: 29481944
[TBL] [Abstract][Full Text] [Related]
39. Effectiveness and Safety of a Paclitaxel-Eluting Stent for Superficial Femoral Artery Lesions up to 190 mm: One-Year Outcomes of the Single-Arm IMPERIAL Long Lesion Substudy of the Eluvia Drug-Eluting Stent.
Golzar J; Soga Y; Babaev A; Iida O; Kawasaki D; Bachinsky W; Park J; Prem JT; Vermassen F; Diaz-Cartelle J; Müller-Hülsbeck S; Gray WA
J Endovasc Ther; 2020 Apr; 27(2):296-303. PubMed ID: 31989856
[No Abstract] [Full Text] [Related]
40. Twelve-Month Results From the MAJESTIC Trial of the Eluvia Paclitaxel-Eluting Stent for Treatment of Obstructive Femoropopliteal Disease.
Müller-Hülsbeck S; Keirse K; Zeller T; Schroë H; Diaz-Cartelle J
J Endovasc Ther; 2016 Oct; 23(5):701-7. PubMed ID: 27193308
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
